Explore our diverse portfolio spanning biological filling equipment, critical anti-inflammatory therapeutics, raw materials, and high-performance industrial components.
Located in the pharmaceutical innovation hub of Hangzhou, Zhejiang Province, Hangzhou Jeci Biochem Technology Co., Ltd. has established itself as an authoritative leader in the global sales, custom synthesis, and co-development of high-quality active pharmaceutical ingredients (APIs), key pharmaceutical intermediates, nutritional products, and specialized food additives.
We bridges the gap between scientific advancement and manufacturing scale. By maintaining key strategic partnerships with leading research laboratories and operating multiple advanced processing factories across China, we deliver dynamic synthesis solutions from milligram assays to multi-ton commercial productions.
For international markets, we are a key partner for organizations in India, Southeast Asia, South Korea, Japan, Europe, and the Americas, providing regulatory guidance, comprehensive product registration services, and targeted market expansion strategies within the Chinese bio-industrial space.
The global market for gastrointestinal (GI) therapeutics is undergoing a profound scientific shift. Historically dominated by simple antacids and general anti-inflammatory agents, the contemporary therapeutic landscape demands highly specialized solutions targeting the microbiome, enteric nervous system, and systemic immune pathways.
Modern clinical pipelines prioritize the development of precision APIs for chronic diseases, such as Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease (GERD), and severe gastroparesis. Global sourcing managers are shifting their attention away from standard, high-volume generic drugs toward advanced molecules requiring multi-step organic synthesis, precise stereochemistry, and high-stability formulation processes.
We leverage advanced synthetic pathways to construct complex heterocyclic intermediates, ensuring structural stability and highly reproducible pharmacological efficacy across commercial batches.
All collaborative facilities undergo regular internal and third-party audits to comply with WHO-GMP, FDA DMF, and local regulatory standards, ensuring seamless international clearance.
From initial benchtop validation (gram scale) to commercial industrial manufacturing (ton scale), our modular production systems adapt to fluctuating global sourcing needs.
China remains the cornerstone of the global Active Pharmaceutical Ingredient (API) supply chain, providing critical structural and economic stability to the global healthcare economy. Key regional hubs, specifically in East China's Zhejiang Province, offer unique geographical and industrial advantages that directly translate to lower risks and cost efficiency for our international partners:
Global pharmaceutical sourcing is governed by regulatory safety nets. At Hangzhou Jeci Biochem, we understand that an API is only as valuable as its accompanying documentation. Our dedicated regulatory affairs department specializes in the preparation and submission of comprehensive CTD (Common Technical Document) dossiers, DMFs, and active registration files for various international health authorities.
For overseas companies looking to enter the fast-growing Chinese market, we act as a local agent, steering complex drug registrations, dietary supplement notifications, and veterinary drug permits through the National Medical Products Administration (NMPA) and the Ministry of Agriculture and Rural Affairs (MARA). Our services include:
We provide professional consultation for factories aiming to upgrade their Quality Management Systems (QMS) to comply with EU-GMP, US-FDA, and PIC/S standards. This includes standardizing sterile filtration validation protocols, environmental monitoring schedules in cleanrooms, validation of analytical chromatography equipment, and trace impurity profiling.
Gastrointestinal formulations manufactured under our guidance are utilized across several specialized clinical and commercial channels:
Our manufacturing sites are equipped with modern processing assets designed to handle complex chemical synthesis. This setup enables batch manufacturing, low-temperature reactions, and high-pressure hydrogenations. Our manufacturing partners maintain strict control over critical parameters such as crystal size distribution, bulk density, and solvent residue limits, ensuring consistent performance in downstream tablet compression and capsule filling.
We optimize processes for key intermediate molecules, balancing yield, safety, and environmental impact. By utilizing automated reactors and inline HPLC tracking, we minimize batch-to-batch variations, helping clients meet production timelines.
Discover our second collection of APIs, intermediates, wellness formulations, and clinical-grade diagnostic consumables.
Technical answers, regulatory guidance, and supply chain insights for global procurement managers.
SJ medical